Joseph Edelman, Director, 10% Owner at Athira Pharma, Inc. (ATHA), bought 1,211,372 shares at $2.28 ($2.9M) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Open-market purchase of $2.9M ATHA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.28 | 32,134 | $73K | 2.5% |
| 2 | $2.28 | 32,134 | $73K | 2.5% |
| 3 | $2.44 | 409,598 | $999K | 34.2% |
| 4 | $2.44 | 409,598 | $999K | 34.2% |
| 5 | $2.38 | 163,954 | $390K | 13.3% |
| 6 | $2.38 | 163,954 |
| $390K |
| 13.3% |
| Total | $2.42 avg | 1,211,372 | $2.9M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| VRCA | BUY | 2023-12-29 | $4.6M | — | Filing → |